Clinical Trial Details
| Trial ID: | L1603 |
| Source ID: | NCT04750460 |
| Associated Drug: | Teriparatide |
| Title: | Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa). |
| Acronym: | TeriCa |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Secondary Hyperparathyroidism|Chronic Kidney Disease-Mineral and Bone Disorder|Dialysis|Hypocalcemia|Hypoparathyroidism |
| Interventions: | DRUG: Teriparatide |
| Outcome Measures: | Primary: Total serum calcium level, Day 1,2,3,4,5 | Secondary: Parathyroid hormone level, Day 1, 2, 3, 4, 5|Serum phosphorus level, Day 1, 2, 3, 4, 5|Serum total alkaline phosphatase level, Day 1, 2, 3, 4, 5|Total serum calcium level, Day 2, 3, 4, 5|Ionized serum calcium level, Day 1, 2, 3, 4, 5|Serious adverse events (major cardiovascular events, fractures, arrhythmia episodes, death), up to 1 week |
| Sponsor/Collaborators: | Sponsor: Saint Petersburg State University, Russia |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE3 |
| Enrollment: | 20 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2021-03-01 |
| Completion Date: | 2022-02-16 |
| Results First Posted: | |
| Last Update Posted: | 2022-11-10 |
| Locations: | Saint-Petersburg State University Hospital, Saint Petersburg, 190103, Russian Federation |
| URL: | https://clinicaltrials.gov/show/NCT04750460 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|